Neurosense Therapeutics Ltd. (NRSN)
2.46
+0.02
(+0.82%)
USD |
NASDAQ |
Oct 23, 16:00
2.43
-0.03
(-1.22%)
After-Hours: 20:00
Neurosense Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 22.12 |
| October 22, 2026 | 21.94 |
| October 21, 2026 | 23.02 |
| October 20, 2026 | 21.49 |
| October 19, 2026 | 23.97 |
| October 16, 2026 | 27.61 |
| October 15, 2026 | 28.51 |
| October 14, 2026 | 27.52 |
| October 13, 2026 | 31.38 |
| October 12, 2026 | 31.29 |
| October 09, 2026 | 32.91 |
| October 08, 2026 | 32.19 |
| October 07, 2026 | 34.35 |
| October 06, 2026 | 36.60 |
| October 05, 2026 | 36.24 |
| October 02, 2026 | 35.39 |
| October 01, 2026 | 36.42 |
| September 30, 2026 | 39.84 |
| September 29, 2026 | 42.98 |
| September 28, 2026 | 45.86 |
| September 25, 2026 | 62.50 |
| September 24, 2026 | 66.55 |
| September 23, 2026 | 66.55 |
| September 22, 2026 | 64.57 |
| September 21, 2026 | 59.53 |
| Date | Value |
|---|---|
| September 18, 2026 | 57.10 |
| September 17, 2026 | 60.43 |
| September 16, 2026 | 58.36 |
| September 15, 2026 | 63.22 |
| September 14, 2026 | 62.05 |
| September 11, 2026 | 62.44 |
| September 10, 2026 | 59.71 |
| September 09, 2026 | 72.12 |
| September 08, 2026 | 75.20 |
| September 04, 2026 | 91.87 |
| September 03, 2026 | 72.23 |
| September 02, 2026 | 73.88 |
| September 01, 2026 | 75.56 |
| August 31, 2026 | 76.74 |
| August 28, 2026 | 75.61 |
| August 27, 2026 | 78.94 |
| August 26, 2026 | 73.56 |
| August 25, 2026 | 68.76 |
| August 24, 2026 | 67.44 |
| August 21, 2026 | 67.68 |
| August 20, 2026 | 63.02 |
| August 19, 2026 | 71.58 |
| August 18, 2026 | 68.70 |
| August 17, 2026 | 77.70 |
| August 14, 2026 | 81.49 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| BioLineRx Ltd. | 0.6472 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 1.663 |
| Can-Fite BioPharma Ltd. | 1.292 |
| Eocene Ltd. | 0.2382 |
Price to Book Value Related Metrics
| Price | 2.46 |
| Market Cap | 80.09M |